24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Debt
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:04
Intel in talks to bring SK Hynix memory production to the US
12:41
Five desalination plants are struggling. Israel won't say how it is making up the difference
12:18
Zuckerberg rejects calls for AI industry-wide slowdown
12:09
Israel's 1.5% inflation rate may be more mirage than reality
More stories
Buzz
Most popular
Daily
Weekly
1
Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction
2
Oracle’s AI transformation gets more expensive as layoffs continue
3
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
4
OpenAI acquires Israeli-founded camera startup Glass Imaging for over $300 million
5
Oracle begins another round of layoffs as $2.8 billion restructuring plan expands
More news
Debt
3 stories about Debt
Teva to Unveil Strategic Plan, Layoffs Thursday
12.12.17
|
Dror Reich
Last month the debt-riddled drug maker announced a rehabilitation plan amidst rumors of upcoming employee cuts
Fitch Downgrades Teva to Junk Rating
07.11.17
|
Yaniv Rahimi
The U.S. credit agency changed Teva's rating from BBB to BB, with a negative outlook, due to "significant operational stress." The downgrade might affect Teva's ability to take on additional debt
There May Be a Silver Lining to Teva’s Woes
06.11.17
|
Eli Shimony
Analysts have lowered their target price for Teva following the company's less than stellar third quarter reports, but the company can still turn its luck around with new drugs and a willingness to tighten the belt
Previous Articles
